Japanese Pharmaceutical Regulations of Engineered Viral Vectors for Medical Use Compared With Those in the United States and the European Union.

Sakurai, Akira; Kanzaki, Seiichi; Honda, Futaba

Sakurai, Akira; Kanzaki, Seiichi; Honda, Futaba.

Afiliación

Sakurai A; Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Kanzaki S; Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
Honda F; Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

Clin Pharmacol Ther ; 113(5): 960-962, 2023 05.

Article en En | MEDLINE | ID: mdl-36404404

Asunto(s)

Industria Farmacéutica; Farmacia; Virus; Industria Farmacéutica/legislación & jurisprudencia; Unión Europea; Preparaciones Farmacéuticas; Estados Unidos; Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Farmacia / Virus / Industria Farmacéutica País/Región como asunto: America do norte / Asia Idioma: En Revista: Clin Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google